These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38934027)

  • 21. Team-Based Medicine: Incorporating a Clinical Pharmacist into Pain and Opioid Practice Management.
    Boren LL; Locke AM; Friedman AS; Blackmore CC; Woolf R
    PM R; 2019 Nov; 11(11):1170-1177. PubMed ID: 30729723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of pharmacist intervention model for chronic kidney disease patients; a prospective comparative study.
    Khokhar A; Khan YH; Mallhi TH; Khan HM; Alotaibi NH; Alzarea AI; Bokharee N
    Int J Clin Pharm; 2020 Apr; 42(2):625-634. PubMed ID: 32026352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug therapy problems and medication discrepancies during care transitions in super-utilizers.
    Surbhi S; Munshi KD; Bell PC; Bailey JE
    J Am Pharm Assoc (2003); 2016; 56(6):633-642.e1. PubMed ID: 27720595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication Therapy Management after Hospitalization in CKD: A Randomized Clinical Trial.
    Tuttle KR; Alicic RZ; Short RA; Neumiller JJ; Gates BJ; Daratha KB; Barbosa-Leiker C; McPherson SM; Chaytor NS; Dieter BP; Setter SM; Corbett CF
    Clin J Am Soc Nephrol; 2018 Feb; 13(2):231-241. PubMed ID: 29295829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns.
    Nkansah N; Mostovetsky O; Yu C; Chheng T; Beney J; Bond CM; Bero L
    Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD000336. PubMed ID: 20614422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postdischarge community pharmacist-provided home services for patients after hospitalization for heart failure.
    Kalista T; Lemay V; Cohen L
    J Am Pharm Assoc (2003); 2015; 55(4):438-42. PubMed ID: 26161487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posthospital Multidisciplinary Care for AKI Survivors: A Feasibility Pilot.
    May HP; Herges JR; Anderson BK; Hanson GJ; Kashani KB; Kattah AG; Cole KC; McCoy RG; Meade LA; Rule AD; Schreier DJ; Tinaglia AG; Barreto EF;
    Kidney Med; 2023 Dec; 5(12):100734. PubMed ID: 37964784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Healthcare Cost Savings of a Pediatric Nephrotoxic Medication-Associated Acute Kidney Injury Reduction Program in a Simulated Sample.
    Dynan L; Lazear D; Goldstein SL
    J Pharm Pract; 2023 Aug; 36(4):795-802. PubMed ID: 35343287
    [No Abstract]   [Full Text] [Related]  

  • 29. Nephrotoxin Exposure in the 3 Years following Hospital Discharge Predicts Development or Worsening of Chronic Kidney Disease among Acute Kidney Injury Survivors.
    Schreier DJ; Rule AD; Kashani KB; Mara KC; Kane-Gill SL; Lieske JC; Chamberlain AM; Barreto EF;
    Am J Nephrol; 2022; 53(4):273-281. PubMed ID: 35294951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of a pharmacist in an interdisciplinary post-cardiac intensive care unit clinic.
    Adie SK; Thompson AN; Konerman MC; Shea MJ; Thomas MP; Thompson AD
    Heart Lung; 2022; 52():48-51. PubMed ID: 34872013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
    Korcegez EI; Sancar M; Demirkan K
    J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of a clinical pharmacy anemia management service on adherence to monitoring guidelines, clinical outcomes, and medication utilization.
    Debenito JM; Billups SJ; Tran TS; Price LC
    J Manag Care Spec Pharm; 2014 Jul; 20(7):715-20. PubMed ID: 24967524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of drug-related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic.
    Shahrami B; Sefidani Forough A; Najmeddin F; Hadidi E; Toomaj S; Javadi MR; Gholami K; Sadeghi K
    J Clin Pharm Ther; 2022 Jul; 47(7):964-972. PubMed ID: 35218217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term Health Care Utilization and Associated Costs After Dialysis-Treated Acute Kidney Injury in Children.
    Robinson CH; Klowak JA; Jeyakumar N; Luo B; Wald R; Garg AX; Nash DM; McArthur E; Greenberg JH; Askenazi D; Mammen C; Thabane L; Goldstein S; Silver SA; Parekh RS; Zappitelli M; Chanchlani R
    Am J Kidney Dis; 2023 Jan; 81(1):79-89.e1. PubMed ID: 35985371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of clinical interventions through a comprehensive medication management program: A retrospective study among outpatients in a private hospital.
    Esteban Zavaleta-Monestel ; Serrano-Arias B; Arguedas-Chacón S; Quirós-Romero A; Díaz-Madriz JP; Villalobos-Madriz A; Robles-Calderón A; Bucknor-Masís J; Chaverri-Fernández JM
    Explor Res Clin Soc Pharm; 2024 Jun; 14():100440. PubMed ID: 38623489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacist-coordinated multidisciplinary hospital follow-up visits improve patient outcomes.
    Cavanaugh JJ; Lindsey KN; Shilliday BB; Ratner SP
    J Manag Care Spec Pharm; 2015 Mar; 21(3):256-60. PubMed ID: 25726034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of a specialist clinical cancer pharmacist at a multidisciplinary lung cancer clinic.
    Walter C; Mellor JD; Rice C; Kirsa S; Ball D; Duffy M; Herschtal A; Mileshkin L
    Asia Pac J Clin Oncol; 2016 Sep; 12(3):e367-74. PubMed ID: 25227909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of a Pharmacist in Postdischarge Care for Patients With Kidney Disease: A Scoping Review.
    Manis MM; Skelley JW; Read JB; Maxson R; O'Hagan E; Wallace JL; Siew ED; Barreto EF; Silver SA; Kane-Gill SL; Neyra JA
    Ann Pharmacother; 2024 Apr; ():10600280241240409. PubMed ID: 38563565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation and evaluation of a shared care model between oncologists and pharmacists for breast cancer patients at a Canadian regional ambulatory cancer centre.
    Goh E; Labelle S; Chan A
    J Oncol Pharm Pract; 2024 Jun; 30(4):622-627. PubMed ID: 37259570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.